These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37935249)

  • 1. Mouse models of accelerated aging in musculoskeletal research for assessing frailty, sarcopenia, and osteoporosis - A review.
    Yılmaz D; Mathavan N; Wehrle E; Kuhn GA; Müller R
    Ageing Res Rev; 2024 Jan; 93():102118. PubMed ID: 37935249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hallmarks of frailty and osteosarcopenia in prematurely aged PolgA
    Scheuren AC; D'Hulst G; Kuhn GA; Masschelein E; Wehrle E; De Bock K; Müller R
    J Cachexia Sarcopenia Muscle; 2020 Aug; 11(4):1121-1140. PubMed ID: 32596975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcopenia, osteoporosis and frailty.
    Gielen E; Dupont J; Dejaeger M; Laurent MR
    Metabolism; 2023 Aug; 145():155638. PubMed ID: 37348597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoporosis and Sarcopenia Increase Frailty Syndrome in the Elderly.
    Greco EA; Pietschmann P; Migliaccio S
    Front Endocrinol (Lausanne); 2019; 10():255. PubMed ID: 31068903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal Stem Cell Transplantation for the Treatment of Age-Related Musculoskeletal Frailty.
    Mahindran E; Law JX; Ng MH; Nordin F
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Musculoskeletal system as a target organ of a frailty processes].
    Zlobina IA; Krivtsunov AN; Bogat SV; Prashchayeu KI
    Adv Gerontol; 2015; 28(4):725-728. PubMed ID: 28509462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine models of accelerated aging and musculoskeletal disease.
    Hambright WS; Niedernhofer LJ; Huard J; Robbins PD
    Bone; 2019 Aug; 125():122-127. PubMed ID: 30844492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of the Kynurenine Pathway in the Pathophysiology of Frailty, Sarcopenia, and Osteoporosis.
    Ballesteros J; Rivas D; Duque G
    Nutrients; 2023 Jul; 15(14):. PubMed ID: 37513550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Musculoskeletal health, frailty and functional decline.
    Milte R; Crotty M
    Best Pract Res Clin Rheumatol; 2014 Jun; 28(3):395-410. PubMed ID: 25481423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creatine supplementation for older adults: Focus on sarcopenia, osteoporosis, frailty and Cachexia.
    Candow DG; Chilibeck PD; Forbes SC; Fairman CM; Gualano B; Roschel H
    Bone; 2022 Sep; 162():116467. PubMed ID: 35688360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated therapies for osteoporosis and sarcopenia: from signaling pathways to clinical trials.
    Girgis CM
    Calcif Tissue Int; 2015 Mar; 96(3):243-55. PubMed ID: 25633430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring the musculoskeletal aging phenotype.
    Dawson A; Dennison E
    Maturitas; 2016 Nov; 93():13-17. PubMed ID: 27131919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aging, Osteo-Sarcopenia, and Musculoskeletal Mechano-Transduction.
    Leser JM; Harriot A; Buck HV; Ward CW; Stains JP
    Front Rehabil Sci; 2021; 2():. PubMed ID: 36004321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aging-related frailty and sarcopenia. Efficacy of osteoporosis treatment drugs for frailty and sarcopenia.].
    Watanabe T; Matsui Y
    Clin Calcium; 2018; 28(9):1263-1267. PubMed ID: 30146514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nrf2 deficiency exacerbates frailty and sarcopenia by impairing skeletal muscle mitochondrial biogenesis and dynamics in an age-dependent manner.
    Huang DD; Fan SD; Chen XY; Yan XL; Zhang XZ; Ma BW; Yu DY; Xiao WY; Zhuang CL; Yu Z
    Exp Gerontol; 2019 May; 119():61-73. PubMed ID: 30690066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Creatine supplementation and aging musculoskeletal health.
    Candow DG; Chilibeck PD; Forbes SC
    Endocrine; 2014 Apr; 45(3):354-61. PubMed ID: 24190049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multisystem derangements in frailty and sarcopenia: a source for biomarker discovery.
    Picca A; Calvani R; Marzetti E
    Curr Opin Clin Nutr Metab Care; 2022 May; 25(3):173-177. PubMed ID: 35238804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aging-related frailty and sarcopenia. Frailty - Sarcopenia and biomarker.].
    Inoue A; Kuzuya M; Cheng X
    Clin Calcium; 2018; 28(9):1191-1200. PubMed ID: 30146504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between Circulating Osteoprogenitor Cells and Sarcopenia.
    Al Saedi A; Phu S; Vogrin S; Gunawardene P; Duque G
    Gerontology; 2022; 68(9):1038-1043. PubMed ID: 34856541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring In Vivo Models of Musculoskeletal Frailty: A Comprehensive Systematic Review.
    Contartese D; Di Sarno L; Salamanna F; Martini L; Fini M; Giavaresi G; Veronesi F
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.